Teca Partners LP Makes New Investment in Option Care Health, Inc. $OPCH

Key Points

• Teca Partners LP has made a new investment of approximately $13.46 million in Option Care Health, Inc., acquiring 385,153 shares, which now represent about 9.7% of their portfolio.
• Insider purchases were notable, with Director Harry M. Jansen Kraemer, Jr. buying 36,000 shares and Director Timothy P. Sullivan acquiring 20,000 shares, indicating confidence in the company's future.
• Option Care Health recently reported a quarterly earnings per share (EPS) of $0.41, exceeding analyst expectations and showing a 15.4% increase in year-over-year revenue.

Teca Partners LP purchased a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the 1st quarter, according to its most recent filing with the SEC. The institutional investor purchased 385,153 shares of the company's stock, valued at approximately $13,461,000. Option Care Health makes up about 9.7% of Teca Partners LP's investment portfolio, making the stock its 4th largest holding. Teca Partners LP owned approximately 0.24% of Option Care Health at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in the stock. Walleye Trading LLC boosted its position in shares of Option Care Health by 19.0% in the first quarter. Walleye Trading LLC now owns 30,915 shares of the company's stock worth $1,080,000 after buying an additional 4,946 shares during the period. Walleye Capital LLC acquired a new position in Option Care Health during the 1st quarter worth approximately $6,264,000. Axiom Investors LLC DE lifted its position in Option Care Health by 111.2% during the 1st quarter. Axiom Investors LLC DE now owns 361,615 shares of the company's stock worth $12,638,000 after acquiring an additional 190,417 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its holdings in Option Care Health by 1,492.9% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company's stock worth $31,000 after acquiring an additional 836 shares during the period. Finally, Advantage Alpha Capital Partners LP grew its position in Option Care Health by 78.7% in the first quarter. Advantage Alpha Capital Partners LP now owns 214,619 shares of the company's stock valued at $7,501,000 after acquiring an additional 94,528 shares in the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Option Care Health

In other Option Care Health news, Director Timothy P. Sullivan bought 20,000 shares of the stock in a transaction that occurred on Thursday, August 21st. The shares were purchased at an average cost of $27.51 per share, for a total transaction of $550,200.00. Following the transaction, the director directly owned 49,229 shares in the company, valued at $1,354,289.79. The trade was a 68.43% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Harry M. Jansen Kraemer, Jr. purchased 36,000 shares of Option Care Health stock in a transaction on Wednesday, August 20th. The shares were acquired at an average price of $27.15 per share, with a total value of $977,400.00. Following the transaction, the director directly owned 375,390 shares in the company, valued at $10,191,838.50. This trade represents a 10.61% increase in their position. The disclosure for this purchase can be found here. 0.64% of the stock is owned by company insiders.

Option Care Health Stock Performance

Shares of NASDAQ:OPCH traded up $0.16 during trading on Thursday, reaching $28.75. 1,777,868 shares of the company's stock traded hands, compared to its average volume of 1,850,522. The stock has a market capitalization of $4.67 billion, a P/E ratio of 23.00, a price-to-earnings-growth ratio of 1.74 and a beta of 0.79. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The company has a 50 day moving average of $29.66 and a 200-day moving average of $31.67. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.01. The firm had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The firm's revenue for the quarter was up 15.4% on a year-over-year basis. During the same period last year, the company earned $0.30 earnings per share. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. On average, equities analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the stock. UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th. Barrington Research reissued an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a report on Thursday, July 10th. JMP Securities upped their target price on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research report on Thursday, July 31st. Finally, Citigroup reiterated an "outperform" rating on shares of Option Care Health in a research note on Thursday, July 31st. Eight investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, Option Care Health has an average rating of "Moderate Buy" and an average target price of $35.75.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.